US Patent 7411039 GLP-2 compounds, formulations, and uses thereof
Patent 7411039 was granted and assigned to Novo Nordisk on August, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 14, 2003
Date of Patent
August 12, 2008
Patent Application Number
10685368
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7411039 GLP-2 compounds, formulations, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
